期刊文献+

Systems biology and OMIC data integration to understand gastrointestinal cancers 被引量:1

下载PDF
导出
摘要 Gastrointestinal(GI)cancers are a set of diverse diseases affecting many parts/organs.The five most frequent GI cancer types are esophageal,gastric cancer(GC),liver cancer,pancreatic cancer,and colorectal cancer(CRC);together,they give rise to 5 million new cases and cause the death of 3.5 million people annually.We provide information about molecular changes crucial to tumorigenesis and the behavior and prognosis.During the formation of cancer cells,the genomic changes are microsatellite instability with multiple chromosomal arrangements in GC and CRC.The genomically stable subtype is observed in GC and pancreatic cancer.Besides these genomic subtypes,CRC has epigenetic modification(hypermethylation)associated with a poor prognosis.The pathway information highlights the functions shared by GI cancers such as apoptosis;focal adhesion;and the p21-activated kinase,phosphoinositide 3-kinase/Akt,transforming growth factor beta,and Toll-like receptor signaling pathways.These pathways show survival,cell proliferation,and cell motility.In addition,the immune response and inflammation are also essential elements in the shared functions.We also retrieved information on protein-protein interaction from the STRING database,and found that proteins Akt1,catenin beta 1(CTNNB1),E1A binding protein P300,tumor protein p53(TP53),and TP53 binding protein 1(TP53BP1)are central nodes in the network.The protein expression of these genes is associated with overall survival in some GI cancers.The low TP53BP1 expression in CRC,high EP300 expression in esophageal cancer,and increased expression of Akt1/TP53 or low CTNNB1 expression in GC are associated with a poor prognosis.The Kaplan Meier plotter database also confirmed the association between expression of the five central genes and GC survival rates.In conclusion,GI cancers are very diverse at the molecular level.However,the shared mutations and protein pathways might be used to understand better and reveal diagnostic/prognostic or drug targets.
出处 《World Journal of Clinical Oncology》 CAS 2022年第10期762-778,共17页 世界临床肿瘤学杂志(英文版)
  • 相关文献

参考文献6

二级参考文献42

  • 1刘鹏,李大疆,覃海德,张如华,陈丽珍,曾益新.鼻咽癌组织中PIK3CA基因热点突变区的突变筛查[J].癌症,2007,26(1):15-20. 被引量:3
  • 2孙喜斌,刘志才,刘曙正,李变云,戴涤新,全培良,程兰平,陆建邦.林州市食管癌和胃癌的发病水平及变化趋势[J].中华肿瘤杂志,2007,29(10):764-767. 被引量:22
  • 3Bagrodia S, Cerione RA. Pak to the future. Trends Cell Biol 1999; 9: 350-5. 被引量:1
  • 4Bokoch GM. Biology of the p21-activated kinases. Annu Rev Biochem 2003; 72: 743-81. 被引量:1
  • 5Sells MA, ChernoffJ. Emerging from the Pak:the p21-activated protein kinase family. Trends Cell Biol 1997; 7: 162-7. 被引量:1
  • 6Jaffer ZM, Chernoff J. p21-activated kinases: three more join the Pak. IntJ Biochem Cell B 2002; 34: 713-7. 被引量:1
  • 7Pandey A, Dan I, Kristiansen TZ, Watanabe NM, Voldby J, Kajikawa E, et al. Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain. Oncogene 2002; 21: 3939-48. 被引量:1
  • 8Cotteret S, Jaffer ZM, Beeser A, Chernoff J. p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol Cell Biol 2003; 23: 5526-39. 被引量:1
  • 9Wu X, Frost JA. Multiple Rho proteins regulate thesubcellular targeting of PAK5. Biochem Bioph Res Commun 2006; 351: 328-35. 被引量:1
  • 10Cotteret S, Chernoff J. Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties. Mol Cell Biol 2006; 26: 3215-30. 被引量:1

共引文献276

同被引文献24

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部